Communication to the Editor : Possible Involvement of Pirfenidone Metabolites in the Antifibrotic Action of a Therapy for Idiopathic Pulmonary Fibrosis
-
- Togami Kohei
- Division of Pharmaceutics, Hokkaido Pharmaceutical University School of Pharmacy Department of Biopharmaceutics, School of Pharmaceutical Science, Ohu University
-
- Kanehira Yukimune
- Department of Biopharmaceutics, School of Pharmaceutical Science, Ohu University
-
- Tada Hitoshi
- Division of Pharmaceutics, Hokkaido Pharmaceutical University School of Pharmacy Department of Biopharmaceutics, School of Pharmaceutical Science, Ohu University
書誌事項
- タイトル別名
-
- Possible Involvement of Pirfenidone Metabolites in the Antifibrotic Action of a Therapy for Idiopathic Pulmonary Fibrosis
この論文をさがす
抄録
Pirfenidone (PFD) is the first and only clinically used antifibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF). This study evaluated the antifibrotic effects of two metabolites of PFD, 5-hydroxypirfenidone (PFD-OH) and 5-carboxypirfenidone (PFD-COOH), on WI-38 cells in an in vitro lung fibroblast model. The inhibitory effects of PFD-OH and PFD-COOH on transforming growth factor-β1 (TGF-β1)-induced collagen synthesis in WI-38 cells were evaluated by measuring intracellular hydroxyproline, a major component of the protein collagen. PFD-OH and PFD-COOH at 300 and 1000 µM concentrations significantly decreased the TGF-β1-induced hydroxyproline content in WI-38 cells. These results indicate that PFD-OH and PFD-COOH have antifibrotic activities, which inhibit collagen synthesis in fibroblasts. This study suggests that the concentrations of PFD and its metabolites should be considered in clinical therapy for IPF.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 36 (10), 1525-1527, 2013
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204632270080
-
- NII論文ID
- 130004147315
-
- NII書誌ID
- AA10885497
-
- COI
- 1:STN:280:DC%2BC2c%2FlvVSruw%3D%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 024872443
-
- PubMed
- 24088250
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可